Dachaigh › Luchd-obrach › Tango Therapeutics, Inc.
Tango Therapeutics, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir Tango Therapeutics, Inc. 7 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 7. Tuarastal meadhanach a chaidh a thabhann: $175,000.
A bheil Tango Therapeutics, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir Tango Therapeutics, Inc. 7 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 5 Ògmh 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Manager, Accounting | 2 | $154,060 |
| Chief Operations Officer-Scientific & Technical Development | 2 | $610,000 |
| Senior Scientist II | 1 | $133,300 |
| Associate Director, Clinical Data Management | 1 | $210,000 |
| Scientist I, Discovery Biology | 1 | $103,500 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 1 | $133,120 |
| FY2024 | 2 | $171,650 |
| FY2025 | 1 | $103,500 |
| FY2026 | 3 | $610,000 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Natural Sciences Managers3
- Accountants and Auditors2
- Medical Scientists, Except Epidemiologists1
- Molecular and Cellular Biologists1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Chief Operations Officer-Scientific & Technical Development | $610,000 Ìre IV | Boston, MA | 5 Ògmh 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Manager, Accounting | $175,000 Ìre IV | Boston, MA | 8 Cèit 2026 | 26 Iuch 2026 | Dearbhaichte |
| Chief Operations Officer-Scientific & Technical Development | $610,000 H-1B1 (Singapore) · Ìre IV | Boston, MA | 13 Màrt 2026 | 1 Cèit 2026 | Dearbhaichte |
| Scientist I, Discovery Biology | $103,500–$125,097 Ìre II | Boston, MA | 19 Cèit 2025 | 30 Sult 2025 | Dearbhaichte |
| Associate Director, Clinical Data Management | $210,000 Ìre II | Boston, MA | 23 Lùna 2024 | 23 Sult 2024 | Dearbhaichte |
| Senior Scientist II | $133,300–$180,300 Ìre III | Boston, MA | 16 Gibl 2024 | 1 Dàmh 2024 | Dearbhaichte |
| Manager, Accounting | $133,120 Ìre IV | Boston, MA | 2 Ògmh 2023 | 26 Iuch 2023 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).